This study, focused on kidney patients, reveals that the patented formulation of Endocalyx Pro restores the endothelial glycocalyx when exposed to toxic hemodialysis plasma.
For the first time, we can now determine quantitative microvascular scores that correlate very well with accepted clinical parameters in individual sepsis patients for a wide range of clinical severitie.
The study, using GlycoCheck endothelial glycocalyx testing technology, measured glycocalyx barrier properties in psoriasis, as well as their correlation with coronary microcirculatory function.
CEO, William Resides announces that as of July 1st, 2022, BioRegenx has moved from due diligence to a binding letter of intent to merge with a public company. These steps also include drafting the definitive agreement for the final merger.
The benefits of PEMF (Pulsed Electro-Magnetic Field) therapy is no secret among wellness experts with a four-year study conducted by NASA to understand its benefits and effects on human wellbeing. NuLife Sciences introduces a portable and affordable PEMF therapy device called the Sedona Face.
VNox+ was carefully crafted for NuLife Sciences to support the production of nitric oxide in the body. The discovery that nitric oxide (NO) is a signaling molecule in the cardiovascular system whereby dilating blood vessels was awarded a Nobel Prize in Physiology or Medicine in 1998.
NuLife Sciences announces the launch of a new range of hydrogen water products to the US market. The new range consists of four primary products: Echo H2 Pitcher, Echo H2 Machine, Echo H2 Server, and Echo H2 Ultimate.